European Medicines Agency panel approves scaling up AstraZeneca COVID vaccine production

Listen to this article:

FILE PHOTO: Needles and a vial of AstraZeneca’s vaccine against coronavirus disease (COVID-19) are pictured during a pilot test which aims to apply 20,000 vaccines per day in coming months, at Fira de Montjuic in Barcelona, Spain, April 26, 2021. REUTERS/Nacho Doce

(Reuters) – A panel of the European drug regulator on Monday approved scaling up manufacturing of AstraZeneca’s COVID-19 vaccine.

An existing manufacturing site operated by Universal Farma in Guadalajara, Spain, will add a second filling line for the vaccine, the European Medicines Agency’s human medicines committee said in a statement.

The scaling up is expected to support the continued supply of the vaccine, including for donations to third countries through COVAX.

Array
(
    [post_type] => post
    [post_status] => publish
    [orderby] => date
    [order] => DESC
    [update_post_term_cache] => 
    [update_post_meta_cache] => 
    [cache_results] => 
    [category__in] => 1
    [posts_per_page] => 4
    [offset] => 0
    [no_found_rows] => 1
    [date_query] => Array
        (
            [0] => Array
                (
                    [after] => Array
                        (
                            [year] => 2024
                            [month] => 02
                            [day] => 02
                        )

                    [inclusive] => 1
                )

        )

)